Задать технический вопрос по продукту
Запросить инструкцию на русском
Clinical Cancer Research
Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer.Biochemical and Biophysical Research Communications
Oxidized low-density lipoprotein promotes osteoclast differentiation from CD68 positive mononuclear cells by regulating HMGB1 releaseBiochemical Clinics
Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profilingBiomedical Research
Correlation between high mobility group box 1 protein, tumor necrosis factor-α, and acute coronary syndromeBiomedicine & Pharmacotherapy
SIRT1 inhibits releases of HMGB1 and HSP70 from human umbilical vein endothelial cells caused by IL-6 and the serum from a preeclampsia patient and protects the cells from deathBMC Complementary and Alternative Medicine
Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure timesIntegrative Cancer Science and Therapeutics
The expression of HMGB1 and the receptor for advanced glycation end products (RAGE) in epithelial ovarian cancerMolecular Cancer
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapyNature microbiology
Secreted tryptophanyl-tRNA synthetase as a primary defence system against infectionStem Cell Rev and Rep
Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton’s Jelly Mesenchymal Stem Cell Conditioned MediumActa Biochimica et Biophysica Sinica
IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECsBiomark Insights
Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with AutismEvidence-based Complementary and Alternative Medicine
ATF3 Protects against LPS-Induced Inflammation in Mice via Inhibiting HMGB1 ExpressionACTA biochimica polonica
High mobility group B1 levels in sepsis and disseminated intravascular coagulationViral Immunology
Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?Microbiology and Immunology
Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosisRheumatology International
Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of lifeInternational of Rheumatic disesases
Serum levels of high mobility group box 1 protein and its association with quality of life and psychological and functional status in patients with fibromyalgiaBMC pulmonary medicine
Soluble receptor for advanced glycation end-products and progression of airway diseaseScandinavian Journal of Trauma, Resuscitation and Emergency Medicine
High mobility group box protein-1 (HMGB-1) as a new diagnostic marker in patients with acute appendicitisJ Cardiothorac Surg.
High plasma levels of high mobility group box 1 is associated with the risk of sepsis in severe blunt chest trauma patients: a prospective cohort studyBioMed Research International
Effects of Single or Combined Treatments with Radiation and Chemotherapy on Survival and Danger Signals Expression in Glioblastoma Cell LinesVirus Research
High-mobility group box-1, promising serological biomarker for the distinction of human WNV disease severityJournal of Stroke and Cerebrovascular Diseases
Increased VEGF and Decreased SDF-1α in Patients with Silent Brain Infarction Are Associated with Better Prognosis after First-Ever Acute Lacunar StrokeJournal of Surgical Research
Plasma levels of high mobility group box 1 increase in patients with posttraumatic stress disorder after severe blunt chest trauma: a prospective cohort studyJournal of Immunotherapy
Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor ImmunityPLOS ONE
Plasma HMGB-1 Levels in Subjects with Obesity and Type 2 Diabetes: A Cross-Sectional Study in Chinajournal of cardiochoracic surgery
High mobility group box 1 gene polymorphism is associated with the risk of postoperative atrial fibrillation after coronary artery bypass surgeryWorld J Gastroenterol
Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitroActa Biochim Biophys Sin (Shanghai)
High mobility group box1 protein is involved in acute inflammation induced by Clostridium difficile toxin AUnited States Patent Application
COMPOSITIONS AND METHODS FOR INHIBITING HMGB1 ACTIVATION OF MELANOCYTESUnited States Patent Application
METHOD OF MAKING A SKIN CARE COMPOSITIONJournal of Immunology Research
Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis PatientsMolecular Immunology
HMGB1 blockade differentially impacts pulmonary inflammation and defense responses in poly (I:C)/LPS-exposed heart transplant miceJournal of Investigative Surgery
Diagnostic Value of High-Mobility Group Box 1 (HMGB1) Protein in Acute and Perforated AppendicitisJ Cell Biochem
High Mobility Group Box 1 Mediates Interferon-r-Induced Phenotypic Modulation of Vascular Smooth Muscle CellsBiomed Pharmacother.
SIRT1 inhibits releases of HMGB1 and HSP70 from human umbilical vein endothelial cells caused by IL-6 and the serum from a preeclampsia patient and protects the cells from deathIntegrative Cancer Science and Therapeutics
The expression of HMGB1 and the receptor for advanced glycation end products (RAGE) in epithelial ovarian cancerClinical Cancer Research
Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate CancerCancer Immunology, Immunotherapy
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancerBiomedicine & Pharmacotherapy
Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic deathNeurological Sciences
Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in EgyptiansInternational Journal of Gynecology & Obstetrics
Increased serum levels of high mobility group protein B1 and calprotectin in pre‐eclampsiaAdvances in Experimental Medicine and Biology
Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary DiseaseTaiwanese Journal of Obstetrics & Gynecology
HMGB1-RAGE signaling pathway in pPROMCell Death & Disease
DAMPs released by pyroptotic cells as major contributors and therapeutic targets for CAR-T-related toxicitiesMol Cell Biochem
Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of BladderEndocr J
Clinical significance of high mobility group box 1/toll-like receptor 4 in obese diabetic patientsJ Exp Clin Cancer Res
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesotheliomaORL J Otorhinolaryngol Relat Spec
High Mobility Group Box-1 Protein and Interleukin 33 Expression in Allergic RhinitisJ Exp Clin Cancer Res
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesotheliomaAm J Physiol Gastrointest Liver Physiol
Abnormal intestinal milieu in post-traumatic stress disorder is not impacted by treatment that improves symptomsПрименение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Применение:
Набор для определения С3 компонента комплемента (С3) методом ИФА (человек)
ELISA Kit for Anti-Myelin Associated Glycoprotein Antibody (Anti-MAG)Набор для определения антител к миелин-ассоциированному гликопротеину
Trefoil Factor 3, Intestinal (TFF3)Фактор трилистника 3
Vascular Adhesion Protein 1 (VAP1)Белок сосудистой адгезии-1
ELISA kit for IL2 receptorНабор для определения рецептора интерлейкина 2 (IL2R) (человек)
Московский государственный университет
Исследовательский центр им.Алмазова
НЦ вирусологии и биотехнологии "Вектор"
Институт медико-биологических проблем РАН
Институт Цитологии и Генетики СО РАН
Институт физиологии им. Павлова
Сеченовский Университет
МНТК Микрохирургии глаза им.Федорова
МФТИ
Институт экспериментальной медицины
Исследовательский центр им. Дмитрия Рогачева
НИЦ Курчатовский институт
Петербургский институт ядерной физики им. Б.П.Константинова
НИИ глазных болезней им. Гельмгольца
НЦ акушерства, гинекологии и перинатологии им.Кулакова
ИЭФБ РАН им.Сеченова
Национальный исследовательский университет Лобачевского
Томский научный исследовательский медицинский центр
Казанский Федеральный Университет
СЗГМУ им.Мечникова
Балтийский федеральный университет
Научный центр неврологии
Северо-Кавказский федеральный университет
Дальневосточный федеральный университет
ФНКЦ физико-химической медицины
ФНКЦ реаниматологии и реабилитологии
Сибирский федеральный университет
Институт биологии гена РАН
ФИЦ Питания и биотехнологий
Сибирский медицинский университет
Институт биофизики клетки РАН
НИПИ им. Бехтерева
Институт Фундаментальных Проблем Биологии РАН
Институт токсикологии ФМБА России
НИИ Акушерства и гинекологии им. Отта
НИИ Психического здоровья
РМАПО
Красноярский медицинский университет им. Войно-Ясенецкого
Алтайский медицинский университет
Ниармедик
Волгоградский медицинский университет
Новосибирский медицинский университет
РНИОИ
ИБХ РАН им. акад. Шемякина и Овчинникова
Петровакс Фарм
Южно-Уральский государственный университет
ПИМУ
ФНЦ Пищевых систем им.Горбатова РАН